Michael F Kanan - Net Worth and Insider Trading

Michael F Kanan Net Worth

The estimated net worth of Michael F Kanan is at least $1 Million dollars as of 2024-11-13. Michael F Kanan is the VP & Corporate Controller of Sigma-Aldrich Corp and owns about 7,700 shares of Sigma-Aldrich Corp (SIAL) stock worth over $1 Million. Michael F Kanan is also the See Remarks of Avadel Pharmaceuticals PLC and owns about 29,538 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $355,047. Details can be seen in Michael F Kanan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael F Kanan has not made any transactions after 2018-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michael F Kanan

To

Michael F Kanan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael F Kanan owns 1 companies in total, including Avadel Pharmaceuticals PLC (AVDL) .

Click here to see the complete history of Michael F Kanan’s form 4 insider trades.

Insider Ownership Summary of Michael F Kanan

Ticker Comapny Transaction Date Type of Owner
AVDL Avadel Pharmaceuticals PLC 2018-12-14 See Remarks

Michael F Kanan Latest Holdings Summary

Michael F Kanan currently owns a total of 2 stocks. Among these stocks, Michael F Kanan owns 7,700 shares of Sigma-Aldrich Corp (SIAL) as of August 7, 2015, with a value of $1 Million and a weighting of 75.19%. Michael F Kanan also owns 29,538 shares of Avadel Pharmaceuticals PLC (AVDL) as of December 14, 2018, with a value of $355,047 and a weighting of 24.81%.

Latest Holdings of Michael F Kanan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SIAL Sigma-Aldrich Corp 2015-08-07 7,700 139.76 1,076,152
AVDL Avadel Pharmaceuticals PLC 2018-12-14 29,538 12.02 355,047

Holding Weightings of Michael F Kanan


Michael F Kanan Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael F Kanan has made a total of 0 transactions in Sigma-Aldrich Corp (SIAL) over the past 5 years. The most-recent trade in Sigma-Aldrich Corp is the sale of 9,832 shares on August 7, 2015, which brought Michael F Kanan around $1 Million.

According to the SEC Form 4 filings, Michael F Kanan has made a total of 0 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years. The most-recent trade in Avadel Pharmaceuticals PLC is the sale of 8,429 shares on December 14, 2018, which brought Michael F Kanan around $20,988.

Insider Trading History of Michael F Kanan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael F Kanan Trading Performance

GuruFocus tracks the stock performance after each of Michael F Kanan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael F Kanan is -2.05%. GuruFocus also compares Michael F Kanan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael F Kanan within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michael F Kanan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michael F Kanan

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
4 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.54 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.33 LIMIT LIMIT LIMIT LIMIT LIMIT

Michael F Kanan Ownership Network

Ownership Network List of Michael F Kanan

No Data

Ownership Network Relation of Michael F Kanan

Insider Network Chart

Michael F Kanan Owned Company Details

What does Avadel Pharmaceuticals PLC do?

Who are the key executives at Avadel Pharmaceuticals PLC?

Michael F Kanan is the See Remarks of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .

Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary

Over the past 18 months, Michael F Kanan made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net sale of 103,975 shares made by Mark Anthony Mccamish , a net purchase of 4,000 shares made by Thomas S Mchugh , and a net purchase of 14,000 shares made by Geoffrey Michael Glass .

In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 41,000 shares were bought by its insiders, resulting in a net sale of 62,975 shares.

Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Avadel Pharmaceuticals PLC Insider Transactions

No Available Data

Michael F Kanan Mailing Address

Above is the net worth, insider trading, and ownership report for Michael F Kanan. You might contact Michael F Kanan via mailing address: 10-1 Blanchardstown Corporate Park, Ballycoolin, Dublin L2 15.